Hesham A. Abdullah: 2024 has been a momentous year for GSK Oncology
Hesham A. Abdullah, Senior Vice President of Global Head Oncology, Research and Development at GSK and Scientific Advisory Board (SAB) Member at Linden Lake Labs, Incorporation, shared a post on LinkedIn:
“2024 has been a momentous year for GSK Oncology.
As we approach year-end, I’d like to reflect on the incredible progress our Oncology R&D Team has made to help address areas of unmet need and improve outcomes for patients with certain blood cancers and solid tumors.
This year, our team achieved major data and regulatory milestones, expanding our impact, and building the scientific and clinical body of knowledge about the potential of our approved and investigational therapies.
It has been rewarding to see our work presented at key scientific venues like ASCO, ESMO and ASH and to join the broader clinical, scientific and patient communities to share our vision for the future of Oncology.
These successes have enabled the continued evolution and growth of our R&D strategy, including our expansion into additional tumor types, solidifying our position as an emerging leader in these areas.
We’ve also made tremendous progress incorporating data and innovative technology to accelerate our development programs and enhance our ability to focus our research efforts where they can yield the greatest results, I look forward to continued progress in this area.
These advances are only possible because of the remarkable teams who work tirelessly to achieve meaningful progress for the patients we serve.
My colleagues are unyielding in their dedication to driving innovative science to develop the next generation of cancer medicines for the patients who need them most.
I’d like to end this note by thanking the GSK Oncology community (BD, Medical, GPS and R&D) throughout this journey and extending my sincerest gratitude to my leadership team for their unwavering support.
I am confident that 2025 will usher ongoing innovation and scientific advancements that will transform the cancer treatment landscape, and I can’t wait to continue this journey with you.
Hesham Ahmed Abdullah.”
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023